287 related articles for article (PubMed ID: 11888095)
1. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
[TBL] [Abstract][Full Text] [Related]
2. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
3. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
Varila E; Wahlström T; Rauramo I
Fertil Steril; 2001 Nov; 76(5):969-73. PubMed ID: 11704119
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
5. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
[TBL] [Abstract][Full Text] [Related]
6. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
Wildemeersch D; Janssens D; Weyers S
Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
[TBL] [Abstract][Full Text] [Related]
7. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year.
Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
Acta Obstet Gynecol Scand; 1997 May; 76(5):449-54. PubMed ID: 9197448
[TBL] [Abstract][Full Text] [Related]
9. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of two levonorgestrel-containing hormone replacement therapy regimens of efficacy and tolerability variables.
Gräser T; Rössner P; Schubert K; Müller A; Bönisch U; Oettel M
Maturitas; 1997 Dec; 28(2):169-79. PubMed ID: 9522325
[TBL] [Abstract][Full Text] [Related]
12. The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
Sturdee DW; Rantala ML; Colau JC; Zahradnik HP; Riphagen FE;
Climacteric; 2004 Dec; 7(4):404-11. PubMed ID: 15799612
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy.
Suhonen SP; Holmström T; Allonen HO; Lähteenmäki P
Fertil Steril; 1995 Feb; 63(2):336-42. PubMed ID: 7843440
[TBL] [Abstract][Full Text] [Related]
14. Effects of the combined hormonal replacement drug estradiol valerate/levonorgestrel on climacteric complaints, endometrium and lipid profile of peri- and postmenopausal women.
Georgiev DB; Golbs S; Goudev A
Methods Find Exp Clin Pharmacol; 2001 May; 23(4):197-202. PubMed ID: 11676228
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism.
Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
Maturitas; 1995 Nov; 22(3):199-205. PubMed ID: 8746877
[TBL] [Abstract][Full Text] [Related]
16. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
17. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Bruhat M; Rudolf K; Vaheri R; Kainulainen P; Timonen U; Viitanen A
Maturitas; 2001 Dec; 40(3):259-71. PubMed ID: 11731187
[TBL] [Abstract][Full Text] [Related]
18. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
[TBL] [Abstract][Full Text] [Related]
20. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT.
Boon J; Scholten PC; Oldenhave A; Heintz AP
Maturitas; 2003 Sep; 46(1):69-77. PubMed ID: 12963171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
